Aβ causes memory impairment by disturbing the jak2/stat3 axis in hippocampal neurons

被引:0
|
作者
Chiba, T. [1 ]
Yamada, M. [1 ]
Aiso, S. [1 ]
机构
[1] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Elevation of intracranial soluble amyloid-beta (A beta) levels has been implicated in the pathogenesis of Alzheimer's disease (AD). We here report that phospho(p-) STAT3 levels in hippocampal neurons age-dependently decreased in AD patients. Hippocampal STAT3 activation by colivelin (CLN) treatment completely restored cognitive function in an AD model (Tg2576). Intracerebroventricular (i.c.v.) administration of A beta 1-42 downregulated p-STAT3 while passive immunization with anti-A beta antibody conversely restored hippocampal p-STAT3 levels in Tg2576. Pharmacological inhibition of STAT3 not only downregulated choline acetyltransferase (ChAT) but also desensitized M1-type muscarinic acetylcholine receptor. Thus, we propose a novel hypothesis accounting for memory impairment related to AD: A beta-dependent inactivation of STAT3 causes memory loss through cholinergic dysfunction.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 50 条
  • [1] Aβ causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons
    Chiba, Tomohiro
    Yamada, Marina
    Terashita, Kenzo
    Aiso, Sadakazu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 52P - 52P
  • [2] Amyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons
    T Chiba
    M Yamada
    J Sasabe
    K Terashita
    M Shimoda
    M Matsuoka
    S Aiso
    Molecular Psychiatry, 2009, 14 : 206 - 222
  • [3] Amyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons
    Chiba, T.
    Yamada, M.
    Sasabe, J.
    Terashita, K.
    Shimoda, M.
    Matsuoka, M.
    Aiso, S.
    MOLECULAR PSYCHIATRY, 2009, 14 (02) : 206 - 222
  • [4] The JAK2/STAT3 signaling axis mediates therapeutic effect of Colivelin on memory impairment related to Alzheimer's disease
    Yamada, Marina
    Chiba, Tomohiro
    Sasabe, Jumpei
    Terashita, Kenzo
    Matsuoka, Masaaki
    Aiso, Sadakazu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 79P - 79P
  • [5] Targeting the JAK2/STAT3 axis in Alzheimer's disease
    Chiba, Tomohiro
    Yamada, Marina
    Aiso, Sadakazu
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (10) : 1155 - 1167
  • [6] JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation
    Wang, Kepeng
    Wang, Chihao
    Xiao, Fang
    Wang, Haixia
    Wu, Zhenguo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (49) : 34029 - 34036
  • [7] JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma
    Zheng, Qifan
    Han, Lei
    Dong, Yucui
    Tian, Jing
    Huang, Wei
    Liu, Zhaoyu
    Jia, Xiuzhi
    Jiang, Tao
    Zhang, Jianning
    Li, Xia
    Kang, Chunsheng
    Ren, Huan
    NEURO-ONCOLOGY, 2014, 16 (09) : 1229 - 1243
  • [8] Ephedrine causes retinal damage in SD rats associating with JAK2/STAT3 pathway
    Yin, Yue
    Gong, Di
    Tang, Yan
    Wang, Zhijun
    CUTANEOUS AND OCULAR TOXICOLOGY, 2020, 39 (03) : 254 - 259
  • [9] Targeting the JAK2/STAT3 pathway in ovarian cancer
    Gritsina, Galina
    Xiao, Fang
    O'Brien, Shane W.
    Maglaty, Marisa A.
    Xu, Ren-Huan
    Sigal, Luis J.
    Litwin, Samuel
    Connolly, Denise C.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Depletion of Zinc Causes Osteoblast Apoptosis with Elevation of Leptin Secretion and Phosphorylation of JAK2/STAT3
    Lee, Jennifer K. K.
    Ha, Jung-Heun
    Kim, Do-Kyun
    Kwon, JaeHee
    Cho, Young-Eun
    Kwun, In-Sook
    NUTRIENTS, 2023, 15 (01)